172 related articles for article (PubMed ID: 27088654)
1. Identification and characterization of monoclonal antibodies against GP73 for use as a potential biomarker in liver cancer screening and diagnosis.
Zhang Y; Xi Y; Fang J; Luo S; Wilson JJ; Huang RP
J Immunoassay Immunochem; 2016; 37(4):390-406. PubMed ID: 27088654
[TBL] [Abstract][Full Text] [Related]
2. Development and potential application of a simultaneous multiplex assay of Golgi protein 73 and alpha-fetoprotein for hepatocellular carcinoma diagnosis.
Xiao J; Long F; Peng T; Hu LB; Cai H; Chen R; Chen WL
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3302-3310. PubMed ID: 31081083
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of anti-GP73 monoclonal antibodies and development of double-antibody sandwich ELISA.
Li QW; Chen HB; Li ZY; Shen P; Qu LL; Gong LL; Xu HP; Pang L; Si J
Asian Pac J Cancer Prev; 2015; 16(5):2043-9. PubMed ID: 25773808
[TBL] [Abstract][Full Text] [Related]
4. A study of diagnostic value of golgi protein GP73 and its genetic assay in primary hepatic carcinoma.
Shi Y; Chen J; Li L; Sun Z; Zen L; Xu S; Zhang Y; Zhang L
Technol Cancer Res Treat; 2011 Jun; 10(3):287-94. PubMed ID: 21517136
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a magnetic particles-based chemiluminescence enzyme immunoassay for Golgi protein 73 in human serum.
Liu X; Wan X; Lu S; Zhang L; Yu S; Lu X
Clin Chim Acta; 2015 May; 445():54-9. PubMed ID: 25801213
[TBL] [Abstract][Full Text] [Related]
6. A comparative evaluation of Golgi protein-73, fucosylated hemopexin, α-fetoprotein, and PIVKA-II in the serum of patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
Morota K; Nakagawa M; Sekiya R; Hemken PM; Sokoll LJ; Elliott D; Chan DW; Dowell BL
Clin Chem Lab Med; 2011 Apr; 49(4):711-8. PubMed ID: 21231906
[TBL] [Abstract][Full Text] [Related]
7. Development of an alpha-fetoprotein and Golgi protein 73 multiplex detection assay using xMAP technology.
Wu Y; Ma J; Wang Y; Zhang Y; Hou Y; Zhang C; Sun H; Sun J; Wang Z; Li N
Clin Chim Acta; 2018 Jul; 482():209-214. PubMed ID: 29630871
[TBL] [Abstract][Full Text] [Related]
8. Value of Golgi protein 73 monoclonal antibody in diagnosis of hepatocellular carcinoma.
Wang C; Hua-yu Y; Yi-lei M; Jin-chun Z; Hai-feng X; Gui-yong J; Yan-ling J; Xin-xin C; Xin L; Xin-ting S; Hong-bing Z
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Feb; 33(1):39-44. PubMed ID: 21375936
[TBL] [Abstract][Full Text] [Related]
9. [Detection and evaluation of serum GP73, a resident Golgi glycoprotein, as a marker in diagnosis of hepatocellular carcinoma].
Zhao XY; Li N; Ding HG; Jiang FF
Zhonghua Zhong Liu Za Zhi; 2010 Dec; 32(12):943-5. PubMed ID: 21223806
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of serum Golgi protein 73 for HBV-related primary hepatic carcinoma.
Gao G; Dong F; Xu X; Hu A; Hu Y
Int J Clin Exp Pathol; 2015; 8(9):11379-85. PubMed ID: 26617863
[TBL] [Abstract][Full Text] [Related]
11. [Value of combined detection of GP73 and alpha-fetoprotein in diagonosis of hepatocellular carcinoma].
Wu QP; Xie FY; Meng QL; Mu YY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Apr; 26(2):148-9. PubMed ID: 23002561
[TBL] [Abstract][Full Text] [Related]
12. [Expression profiles and differential diagnostic value of serum Golgi protein-73 in patients with liver cirrhosis and primary hepatic carcinoma].
Yang Y; Xiao L; Mao R; Zhang H; Wen H; Zhao HR; He FP; Zhang YF; Bao YX
Zhonghua Gan Zang Bing Za Zhi; 2012 Dec; 20(12):920-4. PubMed ID: 23522254
[TBL] [Abstract][Full Text] [Related]
13. Golgi protein 73, not Glypican-3, may be a tumor marker complementary to α-Fetoprotein for hepatocellular carcinoma diagnosis.
Wang Y; Yang H; Xu H; Lu X; Sang X; Zhong S; Huang J; Mao Y
J Gastroenterol Hepatol; 2014 Mar; 29(3):597-602. PubMed ID: 24236824
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Value of the Combination of Golgi Protein 73 and Alpha-Fetoprotein in Hepatocellular Carcinoma: A Meta-Analysis.
Dai M; Chen X; Liu X; Peng Z; Meng J; Dai S
PLoS One; 2015; 10(10):e0140067. PubMed ID: 26441340
[TBL] [Abstract][Full Text] [Related]
15. Serum Golgi protein 73 is not a suitable diagnostic marker for hepatocellular carcinoma.
Liu T; Yao M; Liu S; Wang L; Wang L; Hou J; Ma X; Jia J; Zhao J; Zhuang H; Lu F
Oncotarget; 2017 Mar; 8(10):16498-16506. PubMed ID: 28157705
[TBL] [Abstract][Full Text] [Related]
16. The predictive value of Golgi protein 73 in differentiating benign from malignant liver tumors.
Bröker ME; Ijzermans JN; Witjes CD; van Vuuren HJ; de Man RA
PLoS One; 2014; 9(7):e100187. PubMed ID: 25033446
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance and expression of serum Golgi protein 73 in primary hepatocellular carcinoma.
Jiao C; Cui L; Piao J; Qi Y; Yu Z
J Cancer Res Ther; 2018; 14(6):1239-1244. PubMed ID: 30488837
[TBL] [Abstract][Full Text] [Related]
18. [Development of a quantitative serum assay of Golgi protein 73 in hepatocellular carcinoma using xMAP technology].
Wu Y; Wang YP; Ma J; Zhang YH; Sun HQ; Sun JP; Wang ZK; Xu J; Dai YC; Li N
Zhonghua Zhong Liu Za Zhi; 2019 May; 41(5):351-356. PubMed ID: 31137168
[No Abstract] [Full Text] [Related]
19. GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma.
Marrero JA; Romano PR; Nikolaeva O; Steel L; Mehta A; Fimmel CJ; Comunale MA; D'Amelio A; Lok AS; Block TM
J Hepatol; 2005 Dec; 43(6):1007-12. PubMed ID: 16137783
[TBL] [Abstract][Full Text] [Related]
20. The Value of GPC3 and GP73 in Clinical Diagnosis of Hepatocellular Carcinoma.
Jing JS; Ye W; Jiang YK; Ma J; Zhu MQ; Ma JM; Zhou H; Yu LQ; Yang YF; Wang SC
Clin Lab; 2017 Nov; 63(11):1903-1909. PubMed ID: 29226636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
